357 related articles for article (PubMed ID: 23911922)
1. The Matthew Effect and widely prescribed pharmaceuticals lacking environmental monitoring: case study of an exposure-assessment vulnerability.
Daughton CG
Sci Total Environ; 2014 Jan; 466-467():315-25. PubMed ID: 23911922
[TBL] [Abstract][Full Text] [Related]
2. Prioritising pharmaceuticals for environmental risk assessment: Towards adequate and feasible first-tier selection.
Roos V; Gunnarsson L; Fick J; Larsson DG; Rudén C
Sci Total Environ; 2012 Apr; 421-422():102-10. PubMed ID: 22361586
[TBL] [Abstract][Full Text] [Related]
3. Illicit drugs: contaminants in the environment and utility in forensic epidemiology.
Daughton CG
Rev Environ Contam Toxicol; 2011; 210():59-110. PubMed ID: 21170703
[TBL] [Abstract][Full Text] [Related]
4. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.
Ortiz de García S; Pinto GP; García-Encina PA; Irusta Mata RI
J Environ Manage; 2013 Nov; 129():384-97. PubMed ID: 23995140
[TBL] [Abstract][Full Text] [Related]
5. International scientists' priorities for research on pharmaceutical and personal care products in the environment.
Rudd MA; Ankley GT; Boxall AB; Brooks BW
Integr Environ Assess Manag; 2014 Oct; 10(4):576-87. PubMed ID: 24954797
[TBL] [Abstract][Full Text] [Related]
6. The environmental risk assessment of human pharmaceuticals in the overall EU regulatory affairs process.
Laenge R; Steger-Hartmann T; Schweinfurth H
Regul Toxicol Pharmacol; 2006 Aug; 45(3):223-8. PubMed ID: 16716476
[TBL] [Abstract][Full Text] [Related]
7. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001.
Straub JO
Toxicol Lett; 2002 May; 131(1-2):137-43. PubMed ID: 11988366
[TBL] [Abstract][Full Text] [Related]
8. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients.
Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
Sci Total Environ; 2006 Jul; 364(1-3):67-87. PubMed ID: 16257037
[TBL] [Abstract][Full Text] [Related]
9. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001.
Straub JO
Toxicol Lett; 2002 Oct; 135(3):231-7. PubMed ID: 12270681
[TBL] [Abstract][Full Text] [Related]
10. Prioritization of pharmaceuticals based on risks to aquatic environments in Kazakhstan.
Aubakirova B; Beisenova R; Boxall AB
Integr Environ Assess Manag; 2017 Sep; 13(5):832-839. PubMed ID: 28120523
[TBL] [Abstract][Full Text] [Related]
11. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation.
Besse JP; Garric J
Toxicol Lett; 2008 Jan; 176(2):104-23. PubMed ID: 18077113
[TBL] [Abstract][Full Text] [Related]
12. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment.
Cunningham VL; Binks SP; Olson MJ
Regul Toxicol Pharmacol; 2009 Feb; 53(1):39-45. PubMed ID: 19013494
[TBL] [Abstract][Full Text] [Related]
13. WikiPharma - a freely available, easily accessible, interactive and comprehensive database for environmental effect data for pharmaceuticals.
Molander L; Gerstrand M; Rudén C
Regul Toxicol Pharmacol; 2009 Dec; 55(3):367-71. PubMed ID: 19720105
[TBL] [Abstract][Full Text] [Related]
14. Exploiting monitoring data in environmental exposure modelling and risk assessment of pharmaceuticals.
Boxall AB; Keller VD; Straub JO; Monteiro SC; Fussell R; Williams RJ
Environ Int; 2014 Dec; 73():176-85. PubMed ID: 25127044
[TBL] [Abstract][Full Text] [Related]
15. Assessment of risks to ground-feeding songbirds from lead in the Coeur d'Alene Basin, Idaho, USA.
Sample BE; Hansen JA; Dailey A; Duncan B
Integr Environ Assess Manag; 2011 Oct; 7(4):596-611. PubMed ID: 21793201
[TBL] [Abstract][Full Text] [Related]
16. Reporting and evaluation criteria as means towards a transparent use of ecotoxicity data for environmental risk assessment of pharmaceuticals.
Ågerstrand M; Küster A; Bachmann J; Breitholtz M; Ebert I; Rechenberg B; Rudén C
Environ Pollut; 2011 Oct; 159(10):2487-92. PubMed ID: 21763042
[TBL] [Abstract][Full Text] [Related]
17. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
Kavlock R; Dix D
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
[TBL] [Abstract][Full Text] [Related]
18. Chemicals of emerging concern in the Great Lakes Basin: an analysis of environmental exposures.
Klecka G; Persoon C; Currie R
Rev Environ Contam Toxicol; 2010; 207():1-93. PubMed ID: 20652664
[TBL] [Abstract][Full Text] [Related]
19. An approach for assessing human exposures to chemical mixtures in the environment.
Rice G; MacDonell M; Hertzberg RC; Teuschler L; Picel K; Butler J; Chang YS; Hartmann H
Toxicol Appl Pharmacol; 2008 Nov; 233(1):126-36. PubMed ID: 18589469
[TBL] [Abstract][Full Text] [Related]
20. Environmental risk analysis and prioritization of pharmaceuticals in a developing world context.
Mansour F; Al-Hindi M; Saad W; Salam D
Sci Total Environ; 2016 Jul; 557-558():31-43. PubMed ID: 26994791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
